Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 12, 2020, Pages

  Tso, Leopoldo O ^a   Costello, Michael F ^b   Albuquerque, Luiz Eduardo T ^c   Andriolo, Regis B ^d   Macedo, Cristiane R ^e  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b ROYAL HOSPITAL FOR WOMEN   (Australia)

^c Fertivitro Centro de Reprodução Humana   (Brazil)

^d UNIVERSIDADE DO ESTADO DO PARÁ   (Brazil)

^e Brazilian Cochrane Centre   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; FOLLITROPIN; GLUCOSE; GONADOTROPIN; INSULIN; METFORMIN; PLACEBO; ANTIDIABETIC AGENT;

ADULT; ANDROGEN BLOOD LEVEL; BIRTH RATE; DRUG EFFICACY; DRUG SAFETY; ESTRADIOL BLOOD LEVEL; FASTING; FEMALE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; OOCYTE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; COMPLICATION; CONFIDENCE INTERVAL; HYPERANDROGENISM; HYPERINSULINISM; IN VITRO FERTILIZATION; META ANALYSIS; PREGNANCY; PROCEDURES; STATISTICAL BIAS;

ABORTION, SPONTANEOUS; BIAS; CONFIDENCE INTERVALS; FEMALE; FERTILIZATION IN VITRO; HUMANS; HYPERANDROGENISM; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; LIVE BIRTH; METFORMIN; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PLACEBOS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 85098926384     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006105.pub4     Document Type: Review

References (71)

1. An Y, Sun Z, Zhang Y, Liu B, Guan Y, Lu M. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clinical Endocrinology 2014;80(3):425-31. x-wiley/crsRef/15925061 [PMID: 23869585]
2. Cheraghi E, Mehranjani MS, Shariatzadeh MA, Esfahani MH, Ebrahimi Z. N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reproduction, Fertility, and Development 2016;28(6):723-31. x-wiley/crsRef/15925063 [PMID: 25482371]
3. Cheraghi E, Soleimani Mehranjani M, Shariatzadeh MA, Nasr Esfahani MH, Ebrahimi Z. Co-Administration of metformin and N-Acetyl cysteine fails to improve clinical manifestations in PCOS individual undergoing ICSI. International Journal of Fertility & Sterility 2014;8(2):119-28. x-wiley/crsRef/15925064 [PMID: 25083175]
4. Cheraghi E, Soleimani Mehranjani M, Shariatzadeh SMA, Nasr Esfahani MH, Alani B. N-Acetylcysteine compared to metformin, improves the expression profile of growth differentiation factor-9 and receptor tyrosine kinase c-Kit in the oocytes of patients with polycystic ovarian syndrome. International Journal of Fertility & Sterility 2018;11(4):270-8. x-wiley/crsRef/15925065 [PMID: 29043702]
5. Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer. Gynecological Endocrinology 2006;22(5):235-8. x-wiley/crsRef/3100014
6. Fedorcsak P, Dale PO, Storeng R, Abyholm T, Tanbo T. The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial. Gynecological Endocrinology 2003;17:207-14. x-wiley/crsRef/3100016
7. Jacob SL, Brewer C, Tang T, Picton HM, Barth JH, Balen AH. A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial. Human reproduction (Oxford, England) 2016;31(12):2756-64. x-wiley/crsRef/15925067 [ISRCTN21199799] [PMID: 27816925]
8. Kim C, Jeung Y, Moon J, Kang B. Effect of metformin treatment on intrafollicular cytokines, ovarian response to gonadotropin and in vitro fertilization outcome in patients with polycystic ovary syndrome. Fertility and Sterility 2016;106(3 Suppl):e259-60. x-wiley/crsRef/15925069 [CTG: NCT03086005] [CN-01200008]
9. Kjøtrød SB, Romundstad P, von Düring V, Sunde A, Carlsen SM. Prospective, randomized trial of metformin and vitamins for the reduction of plasma homocysteine in insulin-resistant polycystic ovary syndrome. Fertility and Sterility 2008;89(3):635-41. x-wiley/crsRef/3100018
10. Kjotrod S, von Düring V, Sunde A, Carlsen SM. Metformin treatment before IVF/ICSI in polycystic ovary syndrome women: a prospective, randomized, double-blind study. Human Reproduction 2003;18 Suppl 1:42-3. x-wiley/crsRef/3100019
11. Kjotrod SB, von Düring V, Carlsen SM. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Human Reproduction 2004;19(6):1315-22. x-wiley/crsRef/3100020
12. Kjotrod S, Carlsen SM, Rasmussen PE, Holst-Larsen T, Mellembakken J, Thurin-Kjellberg A, et al. Metformin treatment before and during IVF or ICSI in PCOS women with BMI < 28 kg/m2. Human Reproduction 2010;25(Suppl 1):i286-7. x-wiley/crsRef/3100022
13. Kjotrod SB, Carlsen SM, Rasmussen PE, Holst-Larsen T, Mellembakken J, Thurin-Kjellberg A, et al. Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study. Human Reproduction 2011;26(8):2045-53. x-wiley/crsRef/3100023 [CTG: NCT00159575] [PMID: 21606131]
14. Onalan G, Pabuccu R, Goktolga U, Ceyhan T, Bagis T, Cincik M. Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial. Fertility and Sterility 2005;84(3):798-801. x-wiley/crsRef/15925071
15. Palomba S, Falbo A, Carrillo L, Villani MT, Orio F, Russo T, et al. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. Fertility and Sterility 2011;96:1384-90. x-wiley/crsRef/3100027 [CTG: NCT01233206]
16. Qublan HS, Al-Khaderei S, Abu-Salem AN, Al-Zpoon A, Al-Khateeb M, Al-Ibrahim N, et al. Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial. Journal of Obstetrics and Gynecology 2009;29(7):651-5. x-wiley/crsRef/3100029
17. Tang T, Barth JH, Balen AH. Effect of metformin on follicular anti-Mullerian hormone concentrations in women with PCOS undergoing IVF treatment. Human Reproduction 2010;25(Suppl 1):i68. x-wiley/crsRef/15925072
18. Tang T, Glanville J, Orsi N, Barth JH, Balen AH. The use of metformin for women with PCOS undergoing IVF treatment. Human Reproduction 2006;21(6):1416-25. x-wiley/crsRef/3100031
19. Visnova H, Ventruba P, Crha I, Zakova J. Importance of sensitization of insulin receptors in the prevention of ovarian hyperstimulation syndrome [Význam senzitizace inzulinových receptoru pro prevenci ovariálního hyperstimulacního syndromu]. Ceská Gynekologie 2003;68(3):155-62. x-wiley/crsRef/3100033
20. Visnova H, Ventruba P, Crha I, Zakova J. The impact of insulin receptor sensitization on prevention of ovarian hyperstimulation syndrome. Human Reproduction 2002;17 Suppl:180. x-wiley/crsRef/3100034
21. Abdalmageed OS, Farghaly TA, Abdelaleem AA, Abdelmagied AE, Ali MK, Abbas AM. Impact of Metformin on IVF Outcomes in Overweight and Obese Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Controlled Trial. Reproductive Sciences (Thousand Oaks, Calif.) 2019;26(10):1336-42. x-wiley/crsRef/15925074 [PMID: 29576001]
22. Abdalmageed OS, Farghaly TA, Ismail AM, Hurd WW. Impact of metformin on in vitro fertilization outcomes in overweight and obese polycystic ovary syndrome women: a prospective cohort Study. Fertility and Sterility 2016;106(3 Suppl):e262. x-wiley/crsRef/15925075
23. Akbari AF. Evaluating the effect of the metformin treatment on ICSI in infertile PCOS women. Iranian Journal of Reproductive Medicine 2010;8:8. x-wiley/crsRef/15925077
24. Demirol A, Sari T, Girgin B, Kent E, Gurgan T. The effect of metformin treatment on the ICSI cycle outcome in PCOS patients. Human Reproduction 2006;21(Suppl 1):i88. x-wiley/crsRef/3100036
25. Egbase PE, Al Sharhan M, Buzaber M, Grudzinskas JG. Prospective randomised study of metformin in IVF and embryo transfer treatment cycles in obese patients with polycystic ovarian syndrome. Human Reproduction 2001;16 Suppl 1:202. x-wiley/crsRef/3100038
26. Geusa S, Stanziano A, Causio F, Pansini N, Sarcina E. The efficacy of insulin-sensitizing agent (metformin) in PCOS and insulin resistance patients undergoing IVF treatment. Human Reproduction 2002;17 Suppl:115. x-wiley/crsRef/3100040
27. Ghasemi N, Jahaninejad T, Sheida E, Aflatoonian A. Effectiveness of Metformin in treatment of infertility and recurrent pregnancy loss in polycystic ovarian syndrome. Iranian journal of reproductive medicine 2012;10:8. x-wiley/crsRef/15925079
28. He Y, Lu Y, Zhu Q, Wang Y, Lindheim SR, Qi J, et al. Influence of metabolic syndrome on female fertility and in vitro fertilization outcomes in PCOS women. American journal of obstetrics and gynecology 2019;221(2):138. x-wiley/crsRef/15925081
29. Immediata V, Romualdi D, De Cicco S, Tagliaferri V, Di Florio C, Cirella E, et al. Metformin versus myoinositol: which one is better in obese PCOS patients - a crossover study on clinical, endocrine and metabolic effects. Human Reproduction (Oxford, England) 2014;29:i334. x-wiley/crsRef/15925083
30. Kahraman S, Vanlioglu F, Yakin K, Cengiz S, Karlikaya G. A comparative trial of metformin and oral contraceptive pretreatment in patients with polycystic ovary syndrome undergoing ICSI for severe male factor infertility. Fertility and Sterility 2001;76 Suppl 1(3):67. x-wiley/crsRef/3100042
31. Palomba S, Falbo A, Di Cello A, Cappiello F, Tolino A, Zullo F. Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial. Fertility and sterility 2011;96(5):1128-33. x-wiley/crsRef/15925085 [PMID: 21917254]
32. Pourmatroud E, MohamadJafari R. Comparison of metformin and simvastatin administration in women with polycystic ovary syndrome before intracytoplasmic sperm injection cycle; a prospective, randomized, clinical trial. Human Reproduction (Oxford, England) 2014;29:i334-5. x-wiley/crsRef/15925087 [DOI: 10.1093/humrep/29.Supplement_1.1] [CN-01473786]
33. Pourmatroud E, Mohammadjafari R, Roozitalab M. Comparison of Metformin and Simvastatin Administration in Women With Polycystic Ovary Syndrome Before Intra-Cytoplasmic Sperm Injection Cycle: a Prospective, Randomized, Clinical Trial Study. Iranian Red Crescent medical journal 2015;17(12):e20082. x-wiley/crsRef/15925089 [PMID: 26756007]
34. Pourmatroud E, Mohammad Jafari R. Two protocols for pretreatment in women with polycystic ovary syndrome before intracytoplasmic sperm injection cycle; a prospective, randomized, clinical trial. Iranian journal of reproductive medicine 2014;12(6 Suppl 1):4-5. x-wiley/crsRef/15925088 [CN-01107870]
35. Schachter M, Raziel A, Strassburger D, Rotem C, Ron-El R, Friedler S. Prospective, randomized trial of metformin and vitamins for the reduction of plasma homocysteine in insulin-resistant polycystic ovary syndrome. Fertility and Sterility 2007;88(1):227-30. x-wiley/crsRef/3100046
36. Stadtmauer L, Riehl R, Toma S, Talbert L. Use of metformin in patients with PCOS undergoing IVF-ET improves outcomes. International Journal of Gynecology and Obstetrics 2000;70:B41. x-wiley/crsRef/3100048
37. Stadtmauer LA, Riehl RM, Toma SK, Huang S, Barker S, Talbert LM. Metformin treatment of patients with polycystic ovarian syndrome undergoing IVF increases the number of mature oocytes, the fertilization rate and the number of embryos with changes in the levels of insulin-like growth factor. Fertility and Sterility 1999;72 Suppl 1(3):12. x-wiley/crsRef/3100049
38. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM. Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertility and Sterility 2001;75(3):505-9. x-wiley/crsRef/3100051
39. Stadtmauer LA, Wong BC, Oehninger S. Impact of metformin therapy on ovarian stimulation and outcome in 'coasted' patients with polycystic ovary syndrome undergoing in-vitro fertilization. Reproductive Biomedicine Online 2002;5(2):112-6. x-wiley/crsRef/3100053
40. Swanton A, Lighten A, Granne I, McVeigh E, Lavery S, Trew G, et al. Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial. Human Reproduction (Oxford, England) 2011;26(8):2178-84. x-wiley/crsRef/15925091 [DOI: 10.1093/humrep/der120] [CN-01261056]
41. Tasdemir S, Ficicioglu C, Yalti S, Gurbuz B, Basaran T, Yildirim G. The effect of metformin treatment to ovarian response in cases with PCOS. Archives of Gynecology and Obstetrics 2004;269(2):121-4. x-wiley/crsRef/3100055 [PMID: 12764624]
42. Sun D, Yao G, Wu L, Wang J, Zhao Z, Zhai J. The effect of metformin on pregnancy outcome, endometrial receptivity & MIRNAs in endometrium of patients with PCOS undergoing IVF/ICSI. Fertility and sterility 2016;106(3):e260. x-wiley/crsRef/15925093 [CN-01200009]
43. Aboulghar MA, Mansour RT. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Human Reproduction Update 2003;9:275-89.
44. Adashi EY, Resnick CE, D'Ercole AJ, Svoboda ME, Van Wyk JJ. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocrine Review 1985;6:400-20.
45. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, et al. GnRH antagonists are safer than agonists: an update of a Cochrane review. Human Reproduction Update 2011;17:435.
46. Attia GR, Rainey WE, Carr BR. Metformin directly inhibits androgen production in human thecal cells. Fertility and Sterility 2001;76:517-24.
47. Balen A. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Practice & Research. Clinical Obstetrics & Gynaecology 2004;18:685-6.
48. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. Journal of Clinical Endocrinology and Metabolism 1986;62:904-10.
49. Barbieri RL. Induction of ovulation in infertile women with hyperandrogenism and insulin resistance. American Journal of Obstetrics and Gynecology 2000;183:1412-8.
50. Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No: CD005552. [DOI: 10.1002/14651858.CD005552.pub2]
51. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-74.
52. Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs 1995;49:721-49.
53. Rotterdam ESHRE/ASRM - Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 2004;81:19-25.
54. Frank S. Polycystic ovary syndrome. New England Journal of Medicine 1995;333:853-61.
55. McMaster University (developed by Evidence Prime) GRADEpro GDT. Version accessed 7 February 2019. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.
56. Griesinger G, Diedrich K, Tarlatzis BC, Kolibianakis EM. GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reproductive Biomedicine Online 2006;13:628-38.
57. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
58. Jungheim ES, Odibo AO. Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents. Fertility and Sterility 2010;94(7):2659-64.
59. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. Journal of Clinical Endocrinology and Metabolism 1998;83:3078-82.
60. Kocak M, Caliskan E, Simsir C, Haberal A. Metformin therapy improves ovulatory rates, cervical scores and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertility and Sterility 2002;77:101-6.
61. McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV. Summarizing study characteristics and preparing for synthesis. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors(s). version 6.1 edition. Cochrane, 2020.
62. Nardo LG, Rai R. Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects. Gynecology and Endocrinology 2001;15:373-80.
63. Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 1991;72:83-9.
64. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertility and Sterility 2002;77:209-15.
65. Palomba S, Falbo A, Russo T, Orio F, Tolino A, Zullo F. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response. Human Reproduction 2010;25(4):1005-13.
66. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
67. Speroff L, Glass RH, Kase NG. Anovulation and polycystic ovary [Anovulação e o ovário policístico]. In: Clinical Gynecology, Endocrinology and Infertility. 5th edition. São Paulo: Manole, 1995:477-502.
68. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, Piltonen T, Norman RJ and International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human reproduction 2018;33(9):1602-18. [PMID: 30052961]
69. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertility and Sterility 2008;89(3):505-22.
70. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clinical Endocrinology 2004;60(1):1-17.
71. Yarali H, Zeyneloglu HB. Gonadotrophin treatment in patients with polycystic ovary syndrome. Reproductive Biomedicine Online 2004;8:528-37.